I have been a cancer doctor for 40 years and have seen our treatments evolve to embrace precision medicine and immunotherapy, which can be less harmful to patients than conventional forms of ...

Professor Heung Kyu Lee, KAIST Department of Biological Sciences, and Dr. Keun Bon Ku >Immunotherapy, which enhances the ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

from traditional surgical approaches to the combination of radiation and chemotherapy. However, one of the most promising ...

The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...